在进行临床试验中遇到的挑战 孕产前
T Caroline Bank1, Diana Kline2, Maged M Costantine3
1Division of Maternal Fetal Medicine, Department of Obstetrics & Gynecology, The Ohio State University Wexner Medical Center, Columbus, OH, USA. Tracy.Bank@osumc.edu.
孕前的治疗研究面临挑战,因为有史以来一直排除孕妇. 创新正在出现,阿司匹林等药物显示出预防和治疗的前景.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 从历史上看,孕妇被排除在临床试验之外,这导致孕期特异性疾病 (如产前) 的治疗选择有限.
- 对孕产妇发病率和死亡率的认识越来越大,从而增加了对孕妇群体的研究兴趣.
研究的目的:
- 审查关于治疗研究中的挑战和创新的最新数据,以预防和治疗妊娠前.
- 突出需要扩大对妊娠特异性疾病的研究.
主要方法:
- 审查最近的科学文献和数据.
- 分析预孕治疗研究中的挑战和创新.
主要成果:
- 几种常见的药物 (阿司匹林,普拉瓦斯塔丁,甲型胺,埃索梅普拉) 正在研究预防孕前.
- 包括监管,伦理和可行性问题在内的重大挑战使孕妇治疗研究复杂化.
- 尽管面临挑战,这些药物表现有前途,但它们的最佳使用和开发新型治疗方法仍然是必要的.
结论:
- 对于继续进行治疗研究来解决孕前症的急需.
- 优化现有的有前途药物的使用和开发新型治疗方法对于改善孕前管理至关重要.
更多相关视频
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
12:02Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
相关概念视频
Hypertension III: Clinical Manifestations and Diagnostic Studies
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Errors occurring during blood pressure monitoring
Several factors...
Hypertension V: Nursing Management
